Cesano Alessandra 4

What Happened
Alessandra Cesano, a director of Puma Biotechnology, was granted 27,000 restricted stock units (RSUs) on 2026-06-11. The Form 4 reports an acquisition code "A" (award/grant) at $0.00 — this reflects an equity award rather than a cash purchase. The RSUs will convert into shares only if and when they vest under the grant terms.

Key Details

• Transaction date: 2026-06-11; filing date: 2026-06-15 (filed within required time).
• Reported amount: 27,000 RSUs; reported acquisition price: $0.00 (award).
• Shares owned after transaction: not specified in the filing.
• Footnote: RSUs vest in full on the earlier of the one-year anniversary of the grant or the date of the annual shareholder meeting following the grant, subject to Cesano’s continued service.
• Transaction code: A = Award/Grant.

Context
RSUs are a form of compensation that convert into shares only upon vesting; they are not an immediate market purchase or sale. Such awards are common for directors and do not by themselves indicate a buy/sell signal — they reflect compensation and future alignment with shareholder interests.